Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb;42(2):143-144.
doi: 10.1016/j.healun.2022.10.025. Epub 2022 Nov 6.

TTV viral load as a predictor of antibody response to SARS COV-2 vaccination

Daniele Focosi  1 , Andreina Baj  2 , Lorenzo Azzi  2 , Federica Novazzi  2 , Fabrizio Maggi  3
Affiliations
Editorial

TTV viral load as a predictor of antibody response to SARS COV-2 vaccination

Daniele Focosi et al. J Heart Lung Transplant. 2023 Feb.

Abstract

The measure of torquetenovirus (TTV) viremia is widely recognized as an optimal biomarker of an individual immune status. In the context of COVID-19, the predictive role of TTV load with regard to vaccine response has also been demonstrated, suggesting other intriguing applications for this widespread anellovirus.

Keywords: COVID-19; TTV; immune response; torquetenovirus; vaccine.

PubMed Disclaimer

References

    1. Querido S, Calça R, Weigert A, et al. Kinetics of torquetenovirus DNA load in a recent kidney transplant recipient with mild SARS-CoV-2 infection and a failed antibody response. Transpl Infect Dis. 2021;23:e13524. - PMC - PubMed
    1. Forqué L, Albert E, Giménez E, et al. Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: may it help to predict clinical outcomes? J Clin Virol. 2022;148 - PMC - PubMed
    1. Solis M, Gallais F, Garnier-Kepka S, et al. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia. J Clin Virol. 2022;148 - PMC - PubMed
    1. Stincarelli MA, Baj A, Guidotti B, et al. Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19. Virol J. 2022;19:79. - PMC - PubMed
    1. Emmel V, Gama B, de Paula A, Ferreira G, Binato R, Abdelhay E. Can Torque teno virus be a predictor of SARS-CoV-2 disease progression in cancer patients? J Infect Chemother: Official J Japan Society of Chemotherapy. 2022;28:1623–1627. - PMC - PubMed

Publication types